-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CsLMp/F+Gv9Q7DdDRT59KF9xvcmQO+2KG1WUbsozQQHEyOhtPikOn589G889XXEf a3RrZMero7c2xS/gSGHsAQ== 0000912282-06-000979.txt : 20061006 0000912282-06-000979.hdr.sgml : 20061006 20061006122721 ACCESSION NUMBER: 0000912282-06-000979 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20061006 DATE AS OF CHANGE: 20061006 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000806888 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81850 FILM NUMBER: 061133045 BUSINESS ADDRESS: STREET 1: 8900 GLENLYON PARKWAY SUITE 100 CITY: BURNABY STATE: A1 ZIP: V5J 5J8 BUSINESS PHONE: 6046814101 MAIL ADDRESS: STREET 1: 8900 GLENLYON PARKWAY SUITE 100 CITY: BURNABY STATE: A1 ZIP: V5J 5J8 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Iseli Othmar CENTRAL INDEX KEY: 0001374249 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 41 91 942-2030 MAIL ADDRESS: STREET 1: VIA AI RONCHI 7 CITY: PORTA STATE: V8 ZIP: 6948 SC 13G/A 1 iseli13ga_biomed12312005.htm
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

_________________

SCHEDULE 13G/A
(Amendment No. 2)

INFORMATION STATEMENT PURSUANT TO RULES 13D-1
UNDER THE SECURITIES EXCHANGE ACT OF 1934


Response Biomedical Corp.
(Name of Issuer)

Common Shares, without par value
(Title of Class of Securities)

76123L105
(CUSIP Number)

December 31, 2005
(Date of Event Which Requires Filing of this Statement)



Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

      Rule 13d-1(b)

      Rule 13d-1(c)

      Rule 13d-1(d)



CUSIP No. 76123L105 13G Page 2 of 5 Pages


1 Names of Reporting Persons
I.R.S. Identification Nos. of Above Persons
Othmar Iseli
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a)  
(b)  
3 SEC Use Only
  
4 Citizenship or Place of Organization
Switzerland
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With: 		5 Sole Voting Power
6,956,500
6 Shared Voting Power
 
7 Sole Dispositive Power
6,956,500
8 Shared Dispositive Power
 
9 Aggregate Amount Beneficially Owned by Each Reporting Person
6,956,500
10 Check If the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions)
11 Percent of Class Represented by Amount in Row 9
10.0%
12 Type of Reporting Person (See Instructions)
IN




CUSIP No. 76123L105 13G Page 3 of 5 Pages


Item 1 (a) Name of Issuer:
  Response Biomedical Corp.
Item 1 (b) Address of Issuer's Principal Executive Offices:
  100-8900 Glenlyon Parkway, Burnaby, British Columbia, Canada V5J 5J8
Item 2 (a) Name of Person Filing:

Othmar Iseli
Item 2 (b) Address of Principal Business Office or, if none, Residence:
  via ai Ronchi 7, 6948 Porza, Switzerland
Item 2 (c) Citizenship:

Switzerland
Item 2 (d) Title of Class of Securities:

Common Shares, without par value
Item 2 (e) CUSIP Number:
  76123L105

Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:
  (a) |_| Broker or dealer registered under Section 15 of the Act.
  (b) |_| Bank as defined in Section 3(a)(6) of the Act.
  (c) |_| Insurance company as defined in Section 3(a)(19) of the Act.
  (d) |_| Investment company registered under Section 8 of the Investment Company Act.
  (e) |_| An investment adviser in accordance with Rule 13d-1(b)(1) (ii)(E);
  (f) |_| An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);
  (g) |_| A parent holding company, in accordance with Rule 13d-1(b)(ii)(G);
  (h) |_| A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;
  (i) |_| A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940;
  (j) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
       




CUSIP No. 76123L105 13G Page 4 of 5 Pages


Item 4. Ownership.
  (a) Amount beneficially owned:
    6,956,500 common shares, of which 1,875,000 shares are issuable pursuant to warrants expiring on June 18, 2006 at a price per share of Cdn$1.15 and 333,333 shares are issuable pursuant to warrants expiring on December 30, 2006 at a price per share of Cdn$1.50.
  (b) Percent of Class:
    10.0%
  (c) Number of shares as to which such person has:

(i)     Sole power to vote or to direct the vote:   

          6,956,500


(ii)    Shared power to vote or direct the vote:   



(iii)   Sole power to dispose or to direct the disposition of:   

          6,956,500

(iv)    Sole power to dispose or to direct the disposition of:   
Item 5. Ownership of Five Percent or Less of a Class.
  If the statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [  ]
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
  Not applicable.
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
  Not applicable.
Item 8. Identification and Classification of Members of the Group.

Not applicable.
Item 9. Notice of Dissolution of Group.

Not applicable.
Item 10. Certification.
  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.




CUSIP No. 76123L105 13G Page 5 of 5 Pages


SIGNATURE

        After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

  /s/ Othmar Iseli
_____________________________________
Othmar Iseli

Date:   October 3, 2006




GRAPHIC 2 ballot.jpg GRAPHIC begin 644 ballot.jpg M_]C_X``02D9)1@`!`0$!+`$L``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#U."#5-9UW M7U'B/4K&"SO4MX8+6*V*A3;0R$DR0LQ):1N_I6KX5OKC4_!^B7]W()+FZL() MI7``W.T:EC@<#DGI3+GPKI=S>W5V6U"&:Z=9)C;:G GRAPHIC 3 ballotx.jpg GRAPHIC begin 644 ballotx.jpg M_]C_X``02D9)1@`!`0$!+`$L``#_VP!#``@&!@<&!0@'!P<)"0@*#!0-#`L+ M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0`'P$``P$!`0$! M`0$!`0````````$"`P0%!@<("0H+_\0`M1$``@$"!`0#!`<%!`0``0)W``$" M`Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O`58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H`#`,!``(1`Q$`/P#<\6>.]4TK MQOJ>F+JEW'"MQ%%"MO/;1QVJE+7,EP9+>1HXBT[8DR:9]H&YVC4L<#@9)/2H[GPEI5UJ%S?,VI0SW3AYC:ZI -----END PRIVACY-ENHANCED MESSAGE-----